Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rejnmark

Showing results (41-50 of 264) with videos related to

Pageof 27
Sort By:
Calcified Tissue International|May 9, 2008
Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancerPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Calcified Tissue International|December 11, 2008
Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
European Endocrinology|June 7, 2018
Bone Involvement in Primary Hyperparathyroidism and Changes After ParathyroidectomyLars Rolighed, Lars Rejnmark, Peer Christiansen
Current Drug Safety|April 29, 2011
PTH treatment in hypoparathyroidismTanja Sikjaer, Lars Rejnmark, Leif Mosekilde
Epilepsia|October 29, 2004
Fracture risk associated with use of antiepileptic drugsPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|May 6, 2008
[Osteoporosis and fractures associated with drugs]Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 28, 2017
Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control StudyLine Underbjerg, Tanja Sikjaer, Lars Rejnmark
Clinical Endocrinology|February 21, 2008
Pre-existing diseases and use of loop diuretics may explain increased mortality in secondary hyperparathyroidismLars Rejnmark, Peter Vestergaard, Leif Mosekilde
International Journal of Cardiology|August 11, 2007
Are fractures due to anticoagulants or the disease necessitating the treatment?Lars Rejnmark, Peter Vestergaard, Leif Mosekilde
Calcified Tissue International|August 21, 2007
Fracture risk associated with parkinsonism and anti-Parkinson drugsPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Pageof 27

Showing results (41-50 of 264) with videos related to

Sort By:
Pageof 27
Calcified Tissue International|May 9, 2008
Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancerPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Calcified Tissue International|December 11, 2008
Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetesPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
European Endocrinology|June 7, 2018
Bone Involvement in Primary Hyperparathyroidism and Changes After ParathyroidectomyLars Rolighed, Lars Rejnmark, Peer Christiansen
Current Drug Safety|April 29, 2011
PTH treatment in hypoparathyroidismTanja Sikjaer, Lars Rejnmark, Leif Mosekilde
Epilepsia|October 29, 2004
Fracture risk associated with use of antiepileptic drugsPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|May 6, 2008
[Osteoporosis and fractures associated with drugs]Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 28, 2017
Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control StudyLine Underbjerg, Tanja Sikjaer, Lars Rejnmark
Clinical Endocrinology|February 21, 2008
Pre-existing diseases and use of loop diuretics may explain increased mortality in secondary hyperparathyroidismLars Rejnmark, Peter Vestergaard, Leif Mosekilde
International Journal of Cardiology|August 11, 2007
Are fractures due to anticoagulants or the disease necessitating the treatment?Lars Rejnmark, Peter Vestergaard, Leif Mosekilde
Calcified Tissue International|August 21, 2007
Fracture risk associated with parkinsonism and anti-Parkinson drugsPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Pageof 27